NCT01616173View on ClinicalTrials.gov

Analgesic Benefits of Perineural Versus Intravenous Dexamethasone in Patients Receiving Sciatic Nerve Block

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

June 30, 2013

Conditions
Fracture of Ankle
Interventions
DRUG

Dexamethasone

IV dexamethsone 8mg in 50mL (diluted in NS)

DRUG

Dexamethasone

8mg/2mL

DRUG

Saline

2mL

Trial Locations (1)

60611

Northwestern University, Feinberg School of Medicine, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01616173 - Analgesic Benefits of Perineural Versus Intravenous Dexamethasone in Patients Receiving Sciatic Nerve Block | Biotech Hunter | Biotech Hunter